Rexall Greens Capsules
Natural health product licensed in Canada
- Licence holder
- P.L. Nutrition Inc.
- NPN or DIN-HM
- 80009874
- Status
- Inactive licence
- Licence date
- 28 April 2009
- Revision date
- 30 December 2014
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Camellia sinensis Source : Feuille(s) Extraction ratio : 20:1 Dry plant equivalent : 25 mg Potency : 90 % Polyphenols | 1.25 mg | Not calculated |
| Ginkgo biloba Source : Feuille(s) Extraction ratio : 50:1 Dry plant equivalent : 80 mg Potency : 24 % Ginkgo flavonglycosides | 1.6 mg | Not calculated |
| Ginkgo biloba Source : Feuille(s) Potency : 6 % Terpene lactones | Not specified | Not calculated |
| Lactobacillus rhamnosus Source : Isolated from dehydrated milk (R0011) | 0.036 Milliards d'UFC | Not calculated |
| Lactobacillus casei Source : Isolated from dehydrated fermented milk (R0215) | 0.0075 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : Isolated from human adult intestine (R0071) | 0.0033 Milliards d'UFC | Not calculated |
| Beta vulgaris Source : Racine | 3.6 mg | Not calculated |
| Hordeum vulgare Source : Herbe(s) | 61.3 mg | Not calculated |
| Medicago sativa Source : Herbe(s) | 32.5 mg | Not calculated |
| Glycyrrhiza uralensis Source : Racine Extraction ratio : 5:1 Dry plant equivalent : 41.5 mg Potency : 10 % Glycyrrhizin | 8.3 mg | Not calculated |
| Spinacia oleracea Source : Feuille(s) | 12.5 mg | Not calculated |
| Triticum aestivum Source : Herbe(s) | 31.9 mg | Not calculated |
| Spirulina platensis Source : Cells | 127.9 mg | Not calculated |
| Daucus carota Source : Racine | 12.5 mg | Not calculated |
| Malpighia glabra Source : Berry juice Potency : 18 % Vitamin C | 8.3 mg | Not calculated |
| Ascophyllum nodosum Source : Algues | 1.6 mg | Not calculated |
| Lactobacillus helveticus Source : Isolated from dairy source (R0052) | 0.016 Milliards d'UFC | Not calculated |
| Brassica oleracea Source : Tige(s) | 12.5 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Gélatine, Eau, Stevia
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 12 Capsule | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
An antioxidant for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80009874
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed. Photograph the packaging